• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例消融术后心包积液病例。

A Case of Postablation Pericardial Effusion.

作者信息

Ziffra Jeffrey B, Germano Nicholas D, Phillips Angela N, Olshansky Brian

机构信息

Department of Cardiology, Mercy Medical Center, Mason City, IA, USA.

Department of Medicine, Des Moines University, Des Moines, IA, USA.

出版信息

J Innov Card Rhythm Manag. 2018 Oct 15;9(10):3365-3368. doi: 10.19102/icrm.2018.091002. eCollection 2018 Oct.

DOI:10.19102/icrm.2018.091002
PMID:32477786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252661/
Abstract

Complications of atrial fibrillation ablation include pericardial effusion, which tends to occur acutely. Large and hemodynamically important effusions are uncommon, but a small effusion may be present at the end of the procedure in up to 22% of ablations. We monitor for pericardial effusions routinely after ablation with intracardiac echocardiography. However, the follow-up of a small effusion present immediately after ablation remains uncertain, especially with the use of dabigatran or another novel oral anticoagulant. There are no current recommendations on the follow-up of small pericardial effusions after ablation. We present a case and ask a panel of experts for their opinions.

摘要

心房颤动消融术的并发症包括心包积液,心包积液往往急性发生。大量且具有血流动力学意义的积液并不常见,但在高达22%的消融术中,术后可能会出现少量积液。我们在消融术后常规通过心腔内超声心动图监测心包积液。然而,消融术后即刻出现的少量积液的后续情况仍不明确,尤其是在使用达比加群或其他新型口服抗凝剂的情况下。目前对于消融术后少量心包积液的随访尚无相关建议。我们呈现了一个病例并征求了专家小组的意见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0856/7252661/347bb418e4ae/icrm-09-3365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0856/7252661/8d8094d283da/icrm-09-3365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0856/7252661/347bb418e4ae/icrm-09-3365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0856/7252661/8d8094d283da/icrm-09-3365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0856/7252661/347bb418e4ae/icrm-09-3365-g002.jpg

相似文献

1
A Case of Postablation Pericardial Effusion.一例消融术后心包积液病例。
J Innov Card Rhythm Manag. 2018 Oct 15;9(10):3365-3368. doi: 10.19102/icrm.2018.091002. eCollection 2018 Oct.
2
Routine echocardiography after radiofrequency ablation: to flog a dead horse?射频消融术后的常规超声心动图检查:多此一举?
Europace. 2009 Feb;11(2):155-7. doi: 10.1093/europace/eun360. Epub 2008 Dec 24.
3
Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage.肺动脉高压中心包积液:特征、预后和引流的作用。
Chest. 2013 Nov;144(5):1530-1538. doi: 10.1378/chest.12-3033.
4
Intracardiac two-dimensional echocardiography in patients with pericardial effusion and cardiac tamponade.心包积液和心脏压塞患者的心腔内二维超声心动图检查
J Am Soc Echocardiogr. 1991 Nov-Dec;4(6):571-6. doi: 10.1016/s0894-7317(14)80215-0.
5
Pericardial effusion in atrial fibrillation ablation: a comparison between cryoballoon and radiofrequency pulmonary vein isolation.心房颤动消融术后的心包积液:冷冻球囊与射频肺静脉隔离的比较。
Europace. 2010 Mar;12(3):337-41. doi: 10.1093/europace/eup422. Epub 2010 Jan 6.
6
Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF).房颤导管消融围手术期口服抗凝剂报告:日本房颤导管消融注册研究(J-CARAF)
J Arrhythm. 2017 Jun;33(3):172-176. doi: 10.1016/j.joa.2016.10.002. Epub 2016 Oct 27.
7
Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences.心脏手术后的心包积液:发生率、部位、大小及血流动力学后果。
Br Heart J. 1994 Oct;72(4):327-31. doi: 10.1136/hrt.72.4.327.
8
Intraoperative Management to Prevent Cardiac Collapse in a Patient With a Recurrent, Large-volume Pericardial Effusion and Paroxysmal Atrial Fibrillation During Liver Transplantation: A Case Report.肝移植术中预防复发性大量心包积液及阵发性心房颤动患者心脏骤停的术中管理:一例报告
Transplant Proc. 2019 Mar;51(2):568-574. doi: 10.1016/j.transproceed.2018.12.019. Epub 2019 Jan 3.
9
Massive pleural effusion following high-power and short-duration radiofrequency ablation for treatment of atrial fibrillation: A case report and review of the literature.高功率短程射频消融治疗心房颤动后出现大量胸腔积液:一例病例报告及文献复习
Front Cardiovasc Med. 2022 Oct 14;9:996481. doi: 10.3389/fcvm.2022.996481. eCollection 2022.
10
Successful nonsurgical treatment of esophagopericardial fistulas after atrial fibrillation catheter ablation: a case series.房颤导管消融术后并发食管-心包瘘的成功非手术治疗:病例系列。
Circ Arrhythm Electrophysiol. 2013 Aug;6(4):675-81. doi: 10.1161/CIRCEP.113.000384. Epub 2013 May 31.

引用本文的文献

1
Post-cardiac injury syndrome after a concealed accessory pathway ablation.隐匿性旁路消融术后的心包损伤综合征
J Cardiol Cases. 2022 Jan 5;25(6):351-353. doi: 10.1016/j.jccase.2021.12.007. eCollection 2022 Jun.
2
Managing Postablation Pericardial Effusion.处理消融术后心包积液
J Innov Card Rhythm Manag. 2018 Oct 15;9(10):3369-3371. doi: 10.19102/icrm.2018.091001. eCollection 2018 Oct.

本文引用的文献

1
Safety And Efficacy Of Uninterrupted Periprocedural Apixaban In Patients Undergoing Atrial Fibrillation Catheter Ablation: A Metaanalysis Of 1,057 Patients.心房颤动导管消融患者围手术期不间断使用阿哌沙班的安全性和有效性:1057例患者的荟萃分析
J Atr Fibrillation. 2016 Apr 30;8(6):1368. doi: 10.4022/jafib.1368. eCollection 2016 Apr-May.
2
Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.与维生素K拮抗剂相比,阿哌沙班及阿哌沙班不间断治疗用于房颤导管消融患者的疗效和安全性的荟萃分析。
J Interv Card Electrophysiol. 2017 Mar;48(2):223-233. doi: 10.1007/s10840-016-0195-5. Epub 2016 Oct 22.
3
Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials.
口服Xa因子抑制剂与维生素K拮抗剂治疗非瓣膜性心房颤动患者的安全性和有效性:II期和III期随机对照试验的荟萃分析
Int J Cardiol. 2016 Sep 1;218:235-239. doi: 10.1016/j.ijcard.2016.05.059. Epub 2016 May 14.
4
Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.使用不间断因子Xa抑制剂消融心房颤动后围手术期和早期心包积液伴心脏压塞的管理:病例系列
J Cardiovasc Electrophysiol. 2016 Apr;27(4):399-403. doi: 10.1111/jce.12918. Epub 2016 Feb 17.
5
Postcardiac injury syndrome following vascular interventional radiofrequency ablation for paroxysmal atrial fibrillation.阵发性心房颤动血管介入射频消融术后的心包损伤综合征
Respir Med Case Rep. 2015 Jun 4;15:89-91. doi: 10.1016/j.rmcr.2015.03.008. eCollection 2015.
6
Development of delayed cardiac tamponade 55 days after catheter ablation for atrial fibrillation with a new oral anticoagulant.使用新型口服抗凝剂进行房颤导管消融术后55天发生迟发性心脏压塞。
J Interv Card Electrophysiol. 2014 Nov;41(2):135. doi: 10.1007/s10840-014-9926-7. Epub 2014 Jul 10.
7
Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.接受左心房导管消融术患者围术期持续使用利伐沙班的安全性。
Circ Arrhythm Electrophysiol. 2014 Aug;7(4):576-82. doi: 10.1161/CIRCEP.114.001586. Epub 2014 Jun 26.
8
Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life.秋水仙碱预防肺静脉隔离术后心房颤动复发:中期疗效及对生活质量的影响。
Heart Rhythm. 2014 Apr;11(4):620-8. doi: 10.1016/j.hrthm.2014.02.002. Epub 2014 Feb 4.
9
Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.接受射频消融治疗心房颤动的患者中,不停用利伐沙班进行围手术期抗凝的可行性和安全性:多中心前瞻性注册研究结果。
J Am Coll Cardiol. 2014 Mar 18;63(10):982-8. doi: 10.1016/j.jacc.2013.11.039. Epub 2014 Jan 8.
10
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.2012年心房颤动导管消融与外科消融专家共识声明:患者选择、手术技术、患者管理与随访、定义、终点及研究试验设计的建议:心律学会(HRS)心房颤动导管消融与外科消融特别工作组报告。与欧洲心脏病学会(ESC)注册分支欧洲心律协会(EHRA)及欧洲心脏心律失常学会(ECAS)合作制定;并与美国心脏病学会(ACC)、美国心脏协会(AHA)、亚太心律学会(APHRS)和胸外科医师学会(STS)协作。得到美国心脏病学会基金会、美国心脏协会、欧洲心脏心律失常学会、欧洲心律协会、胸外科医师学会、亚太心律学会和心律学会管理机构的认可。
Heart Rhythm. 2012 Apr;9(4):632-696.e21. doi: 10.1016/j.hrthm.2011.12.016. Epub 2012 Mar 1.